[
  {
    "ts": null,
    "headline": "Nanobiotix Says Early Trial Results Support JNJ-1900 With Chemoradiation in Esophageal Cancer",
    "summary": "Nanobiotix (NBTX) reported early results from the first two cohorts of a phase 1 trial testing its r",
    "url": "https://finnhub.io/api/news?id=899c9264427b6379f58f59c41065f9af9fe063396d56010cfab98ba5feb1a9d4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759353328,
      "headline": "Nanobiotix Says Early Trial Results Support JNJ-1900 With Chemoradiation in Esophageal Cancer",
      "id": 136952176,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Nanobiotix (NBTX) reported early results from the first two cohorts of a phase 1 trial testing its r",
      "url": "https://finnhub.io/api/news?id=899c9264427b6379f58f59c41065f9af9fe063396d56010cfab98ba5feb1a9d4"
    }
  },
  {
    "ts": null,
    "headline": "Drug Stock Rally Helps Push Dow and S&P 500 to Records",
    "summary": "Pharma stocks climbed for a second session, extending gains that began after President  Trump  unveiled a direct-to-consumer website for Americans to buy drugs.  Amgen  and  Merck  both climbed more than 5%, to push the Dow Jones Industrial Average up 0.1% to its second straight record.  Thermo Fisher Biogen  and  Eli Lilly  were among the top gainers in the S&P 500, which added 0.3%.",
    "url": "https://finnhub.io/api/news?id=5bd585c49d43673b5051763e94a1a7fc8e306395cab56ea3da2dff38efde8a23",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759352100,
      "headline": "Drug Stock Rally Helps Push Dow and S&P 500 to Records",
      "id": 136952143,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Pharma stocks climbed for a second session, extending gains that began after President  Trump  unveiled a direct-to-consumer website for Americans to buy drugs.  Amgen  and  Merck  both climbed more than 5%, to push the Dow Jones Industrial Average up 0.1% to its second straight record.  Thermo Fisher Biogen  and  Eli Lilly  were among the top gainers in the S&P 500, which added 0.3%.",
      "url": "https://finnhub.io/api/news?id=5bd585c49d43673b5051763e94a1a7fc8e306395cab56ea3da2dff38efde8a23"
    }
  },
  {
    "ts": null,
    "headline": "Marla Beck Steps Down as CEO of Hydrafacial Owner",
    "summary": "Beck will be succeeded as president and CEO of BeautyHealth by Pedro Malha.",
    "url": "https://finnhub.io/api/news?id=0f7c502ea0d4a35f1e71111300da45447cb3edf22b709053c37dc9ce9162c6d6",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759331485,
      "headline": "Marla Beck Steps Down as CEO of Hydrafacial Owner",
      "id": 136947244,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Beck will be succeeded as president and CEO of BeautyHealth by Pedro Malha.",
      "url": "https://finnhub.io/api/news?id=0f7c502ea0d4a35f1e71111300da45447cb3edf22b709053c37dc9ce9162c6d6"
    }
  },
  {
    "ts": null,
    "headline": "Headlines Boost Pharma Stocks. Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Speak to Rally Into Year End",
    "summary": "FEATURE  Healthcare stocks have found a second wind, with momentum building across biotech and pharmaceuticals.  The cleared the very round $100 level for the first time in 10 months yesterday. The more pharma-specific surged 3.",
    "url": "https://finnhub.io/api/news?id=fcaea91725db69ea6ff5513a4aa5f0b3ea2968ca11f38eac9e1d0fc75987a454",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759331400,
      "headline": "Headlines Boost Pharma Stocks. Charts of Pfizer, Johnson & Johnson, Jazz Pharmaceuticals Speak to Rally Into Year End",
      "id": 136947245,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "FEATURE  Healthcare stocks have found a second wind, with momentum building across biotech and pharmaceuticals.  The cleared the very round $100 level for the first time in 10 months yesterday. The more pharma-specific surged 3.",
      "url": "https://finnhub.io/api/news?id=fcaea91725db69ea6ff5513a4aa5f0b3ea2968ca11f38eac9e1d0fc75987a454"
    }
  },
  {
    "ts": null,
    "headline": "ISRG Expands SP Indications: A Game Changer in Colorectal Surgery?",
    "summary": "Intuitive Surgical's SP platform secures new colorectal clearances, with 88% growth in procedures and rising global adoption momentum.",
    "url": "https://finnhub.io/api/news?id=5dd059186ecfe3336a2a03df6d9643c660d0142929799e7b9e6c6a8ee50b044c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759327980,
      "headline": "ISRG Expands SP Indications: A Game Changer in Colorectal Surgery?",
      "id": 136947246,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "Intuitive Surgical's SP platform secures new colorectal clearances, with 88% growth in procedures and rising global adoption momentum.",
      "url": "https://finnhub.io/api/news?id=5dd059186ecfe3336a2a03df6d9643c660d0142929799e7b9e6c6a8ee50b044c"
    }
  },
  {
    "ts": null,
    "headline": "2025 Dermatology Treatment and Care Market Analysis Report with Impact Analysis of US Tariffs Featuring Novartis, Pfizer, Amgen, GSK, F. Hoffmann-La Roche, J&J, AbbVie, Merck, Bayer, Sanofi",
    "summary": "The global dermatology market is driven by increasing skin disorder prevalence, aging demographics, and technological innovations like teledermatology and nanotechnology. The influence of social media, emerging middle-class markets, and advancements in biologics and transdermal patches also present significant growth opportunities.Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The \"Dermatology Treatment and Care Market With Impact Analysis of US Tariffs (2025 Edition)\" report has been added to Resear",
    "url": "https://finnhub.io/api/news?id=d7e68261cb613c26641b6be3775103fee153cf86174ed801f8f74c35996a6fb1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759325460,
      "headline": "2025 Dermatology Treatment and Care Market Analysis Report with Impact Analysis of US Tariffs Featuring Novartis, Pfizer, Amgen, GSK, F. Hoffmann-La Roche, J&J, AbbVie, Merck, Bayer, Sanofi",
      "id": 136947247,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The global dermatology market is driven by increasing skin disorder prevalence, aging demographics, and technological innovations like teledermatology and nanotechnology. The influence of social media, emerging middle-class markets, and advancements in biologics and transdermal patches also present significant growth opportunities.Dublin, Oct. 01, 2025 (GLOBE NEWSWIRE) -- The \"Dermatology Treatment and Care Market With Impact Analysis of US Tariffs (2025 Edition)\" report has been added to Resear",
      "url": "https://finnhub.io/api/news?id=d7e68261cb613c26641b6be3775103fee153cf86174ed801f8f74c35996a6fb1"
    }
  },
  {
    "ts": null,
    "headline": "GCC Liquid Biopsy Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Bio-Rad, Thermo Fisher Scientific, Johnson & Johnson, Guardant Health, QIAGEN, Sysmex",
    "summary": "The GCC Liquid Biopsy Market is projected to grow from US$ 98.24 million in 2024 to US$ 309.53 million by 2033, at a CAGR of 13.60%. This rapid growth is driven by rising cancer incidence, advances in genomics technology, increased healthcare spending, and government support for precision medicine. Liquid biopsies offer a non-invasive alternative to tissue biopsies, allowing for early cancer detection and personalized treatment. Despite challenges like high costs and regulatory hurdles, the mark",
    "url": "https://finnhub.io/api/news?id=869345e234c9dd75856a98296eca092b47405f2b329ebcf67309f12a7223ace8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759318620,
      "headline": "GCC Liquid Biopsy Market Forecast and Company Analysis Report 2025-2033 Featuring F. Hoffmann-La Roche, Bio-Rad, Thermo Fisher Scientific, Johnson & Johnson, Guardant Health, QIAGEN, Sysmex",
      "id": 136944047,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "The GCC Liquid Biopsy Market is projected to grow from US$ 98.24 million in 2024 to US$ 309.53 million by 2033, at a CAGR of 13.60%. This rapid growth is driven by rising cancer incidence, advances in genomics technology, increased healthcare spending, and government support for precision medicine. Liquid biopsies offer a non-invasive alternative to tissue biopsies, allowing for early cancer detection and personalized treatment. Despite challenges like high costs and regulatory hurdles, the mark",
      "url": "https://finnhub.io/api/news?id=869345e234c9dd75856a98296eca092b47405f2b329ebcf67309f12a7223ace8"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers, Takeda to pool data for AI-based drug discovery",
    "summary": "(Reuters) -Bristol Myers Squibb, Takeda Pharmaceuticals and Astex Pharmaceuticals are coming together to share proprietary data for training an artificial intelligence model to assist drug discovery and development.  The companies are joining a consortium that includes AbbVie and Johnson & Johnson , and will contribute data from several thousand experimentally determined protein–small molecule structures to train an AI model called OpenFold3, life sciences company Apheris said on Wednesday.  The initiative is based on a federated data sharing model, which enables collaboration without exposing sensitive data.",
    "url": "https://finnhub.io/api/news?id=56830a56a9854acb3cb037344cff517e0b1fde231c888d3be6c857c39e534905",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759311087,
      "headline": "Bristol Myers, Takeda to pool data for AI-based drug discovery",
      "id": 136944048,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "(Reuters) -Bristol Myers Squibb, Takeda Pharmaceuticals and Astex Pharmaceuticals are coming together to share proprietary data for training an artificial intelligence model to assist drug discovery and development.  The companies are joining a consortium that includes AbbVie and Johnson & Johnson , and will contribute data from several thousand experimentally determined protein–small molecule structures to train an AI model called OpenFold3, life sciences company Apheris said on Wednesday.  The initiative is based on a federated data sharing model, which enables collaboration without exposing sensitive data.",
      "url": "https://finnhub.io/api/news?id=56830a56a9854acb3cb037344cff517e0b1fde231c888d3be6c857c39e534905"
    }
  },
  {
    "ts": null,
    "headline": "Should You Buy Kenvue Stock After Its 30% Plunge?",
    "summary": "There hasn't been much good news lately for this Johnson & Johnson spinoff.",
    "url": "https://finnhub.io/api/news?id=19076908beff2fcb8e3f502fb48f5c1eceb270f49fd957d91a12ab260d3ee25c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1759308240,
      "headline": "Should You Buy Kenvue Stock After Its 30% Plunge?",
      "id": 136944049,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "JNJ",
      "source": "Yahoo",
      "summary": "There hasn't been much good news lately for this Johnson & Johnson spinoff.",
      "url": "https://finnhub.io/api/news?id=19076908beff2fcb8e3f502fb48f5c1eceb270f49fd957d91a12ab260d3ee25c"
    }
  }
]